Real-time enrollment status for this macular degeneration clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT04567303 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 251 participants |
| Active Locations | 52 sites in the US |
| Sponsor | Hoffmann-La Roche |
| Last Updated on CT.gov | February 4, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT04567303 is currently active_not_recruiting participants. This clinical trial study for macular degeneration is not currently accepting new participants at 52 locations across the United States. The study is sponsored by Hoffmann-La Roche. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04567303 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04567303 was last updated 3 weeks ago (February 4, 2026). HelloStudys verifies this status automatically.